Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-07

Clinical Trial Update: Aripiprazole and Topiramate on Free-Choice Alcohol Use [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports completion of Phase 2 and Phase 3 studies evaluating aripiprazole and topiramate for reducing free-choice alcohol use in indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole)
  • Topamax (Topiramate)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcohol Dependence | Phase 2, Phase 3 | Status: COMPLETED